Washington State Compounder Cited for Unsafe Practices
A June FDA inspection left a Washington state pharmacy and compounder with a Form 483 citing unsafe production practices that could lead to drug contamination.
Source: Drug Industry Daily
A June FDA inspection left a Washington state pharmacy and compounder with a Form 483 citing unsafe production practices that could lead to drug contamination.
Source: Drug Industry Daily